About
Ed Olhava joined Versant in 2026 as a Scientist in Residence with over 20 years of experience leading small molecule drug discovery programs. He previously served as SVP of Preclinical Development at IFM Therapeutics, advised Third Rock Ventures, was the first medicinal chemist at Epizyme, and co-invented NINLARO at Millennium Pharmaceuticals.
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Venture Advisor at Intuitive Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures
Frequently asked questions
- Who is Ed Olhava?
- Ed Olhava joined Versant in 2026 as a Scientist in Residence with over 20 years of experience leading small molecule drug discovery programs. He previously served as SVP of Preclinical Development at IFM Therapeutics, advised Third Rock Ventures, was the first medicinal chemist at Epizyme, and co-invented NINLARO at Millennium Pharmaceuticals.
- Where does Ed Olhava work?
- Ed Olhava is Scientist-in-Residence at Versant Ventures.